The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Selpercatinib efficacy and safety in patients with RET-altered thyroid cancer: A clinical trial update.
 
Eric Jeffrey Sherman
Consulting or Advisory Role - Blueprint Medicines; Cota Healthcare; Eisai; Goldilocks; Lilly; Regeneron; UpToDate
Research Funding - Plexxikon; Regeneron
 
Lori J. Wirth
Consulting or Advisory Role - Bayer; Blueprint Medicines; Eisai; Exelixis; Lilly; Loxo; Merck
Research Funding - Ayala Pharmaceuticals (Inst); Checkmate Pharmaceuticals (Inst); Eisai (Inst); Lilly (Inst)
Expert Testimony - Eisai
 
Manisha H. Shah
Research Funding - Lilly (Inst); Merck (Inst)
 
Maria E. Cabanillas
Honoraria - Loxo/Lilly
Consulting or Advisory Role - Ignyta; Loxo
Research Funding - Eisai; Exelixis; Kura Oncology; Merck; Roche/Genentech
 
Bruce Robinson
Leadership - Cochlear; Mayne Pharma
Stock and Other Ownership Interests - Cochlear; Mayne Pharma
Consulting or Advisory Role - Eisai; Loxo
Speakers' Bureau - Eisai
Travel, Accommodations, Expenses - Eisai
 
Janessa J. Laskin
Honoraria - AstraZeneca; Pfizer; Roche Canada
Consulting or Advisory Role - Amgen; Roche Canada; Takeda
Research Funding - AstraZeneca (Inst); Lilly (Inst); Roche Canada (Inst)
 
Matthias Kroiss
Honoraria - Eisai; Ipsen; Lilly
Consulting or Advisory Role - Bayer; Eisai; Lilly
Research Funding - Ipsen; Lilly
Travel, Accommodations, Expenses - Eisai; Ipsen; Lilly
 
Vivek Subbiah
Consulting or Advisory Role - Helsinn Therapeutics; Loxo; MedImmune; QED Therapeutics; R-Pharm
Research Funding - Abbvie (Inst); Agensys (Inst); Alfasigma (Inst); Amgen (Inst); Amgen (Inst); Bayer (Inst); Berg Pharma (Inst); Blueprint Medicines (Inst); Boston Biomedical (Inst); D3 Oncology Solutions (Inst); Exelixis (Inst); Fujifilm (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Idera (Inst); Incyte (Inst); Inhibrx (Inst); LOXO (Inst); Multivir (Inst); NanoCarrier (Inst); Northwest Biotherapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Takeda (Inst); Turning Point Therapeutics (Inst); Vegenics (Inst)
Travel, Accommodations, Expenses - Bayer; Helsinn Therapeutics; Novartis; PharmaMar
Other Relationship - Medscape
 
Alexander E. Drilon
Honoraria - Foundation Medicine; Medscape; MORE Health; OncLive; Peerview; PeerVoice; Physicans' Education Resource; Research to Practice; Targeted Oncology
Consulting or Advisory Role - 14ner Oncology/Elevation Oncology; Abbvie; Archer; AstraZeneca; Bayer; BeiGene; BerGenBio; Blueprint Medicines; EMD Serono/Merck; Exelixis; Genentech/Roche; Helsinn Therapeutics; Hengrui Therapeutics; Ignyta; Lilly; Loxo; Melendi; Monopteros Therapeutics; Monopteros Therapeutics; MORE Health; Novartis; Pfizer; Remedica; Repare Therapeutics; Takeda/Millennium; TP Therapeutics; Tyra Biosciences; Verastem; Verastem
Research Funding - Foundation Medicine
Patents, Royalties, Other Intellectual Property - Wolters Kluwer (Royalties for Pocket Oncology)
Other Relationship - GlaxoSmithKline; Merck; Pfizer; PharmaMar; Puma Biotechnology; Taiho Pharmaceutical; Teva
 
Jennifer Wright
Employment - Lilly
 
Victoria Soldatenkova
Employment - Lilly
 
Pearl Plernjit French
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Travel, Accommodations, Expenses - Lilly
 
Antoine Italiano
Consulting or Advisory Role - Bayer Health; Daiichi Sankyo; Epizyme; Novartis; Roche; SpringWorks Therapeutics
Research Funding - AstraZeneca; Bayer Holding; Bristol-Myers Squibb; Merck; MSD; Roche
 
Daniela Weiler
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; NSB; Sanofi Aventis GmbH
Expert Testimony - Lilly